Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report


AYGEN B., Demir A. M. , GÜMÜŞ M., Karabay O., KAYMAKOĞLU S., Koksal A. S. , ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.29, no.3, pp.259-269, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 29 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.5152/tjg.2018.18263
  • Title of Journal : TURKISH JOURNAL OF GASTROENTEROLOGY
  • Page Numbers: pp.259-269

Abstract

This consensus report includes expert opinions and recommendations regarding the screening, and if necessary, the follow-up, prophylaxis, and treatment of hepatitis B before the treatment in patients who will undergo immunosuppressive therapy due to the risk of hepatitis B reactivation emergency. To increase awareness regarding the risk of hepatitis B reactivation in immunosuppressive patients, academicians from several university health research and training centers across Turkey came together and discussed the importance of the subject, current status, and issues in accordance with the current literature data and presented solutions.